Healthcare Policy

US Lacks Guaranteed Sick Leave While McConnell Takes Extended Leave

While Senator Mitch McConnell recently experienced an extended period of sick leave due to a fall and pneumonia, his own health circumstances stand in stark contrast to his legislative record. McConnell has historically opposed measures that would guarantee paid sick leave for American workers, even blocking federal benefits during the height of the COVID-19 pandemic. This stance, shared by many in his party, leaves the U.S. as the only wealthy nation without such protections for its workforce.

Read More

Congress Lets Planned Parenthood Medicaid Ban Expire

Planned Parenthood and other reproductive health clinics have regained access to Medicaid funding after a one-year provision defunding them expired and was not renewed by Congress. This marks a significant shift, allowing clinics to bill Medicaid for non-abortion related services, though the previous year’s lack of funding, totaling over $800 million annually for Planned Parenthood alone, resulted in severe consequences. These included the denial of essential services to tens of thousands of patients, the closure of nearly 30 health centers, many in rural or underserved areas, and an overall 25% decrease in Medicaid visits to Planned Parenthood. Despite this restoration, future funding remains uncertain, as states can still independently block Medicaid funds, and anti-abortion advocates are pushing for the defunding ban to be reinstated.

Read More

Millions lose Obamacare coverage as subsidies expire and costs soar

Approximately 3 million fewer Americans held Affordable Care Act health insurance plans in February compared to the previous year, marking a 13% decrease in enrollment. While the U.S. Department of Health and Human Services suggested a federal crackdown on fraudulent enrollment, health analysts attribute the decline to the expiration of federal subsidies on January 1, leading to significant premium increases and a subsequent inability for many to pay. This coverage loss, the first official look at its impact after grace periods expired, comes as affordability remains a top concern for voters heading into the November elections.

Read More

Trump Mandates Medicaid Recipients Work or Lose Benefits

A significant shift is underway for many individuals relying on Medicaid, with a new final rule from the Trump administration now mandating that most beneficiaries between the ages of 19 and 64 demonstrate some form of work activity to continue receiving benefits. This rule, established under the framework of the “One Big Beautiful Bill Act,” outlines the requirements states must implement, detailing expectations for eligibility, exemptions, verification processes, and reporting obligations. Essentially, the core idea is that to receive Medicaid, individuals will need to prove they are either working, engaged in community service, or participating in an approved work program.

This sweeping policy change is a direct result of the significant tax and spending legislation passed by Congress, which incorporated these work requirements as a means to offset its substantial cost.… Continue reading

Federal Employees Barred From Gender Affirming Care Coverage Next Year

The Office of Personnel Management (OPM) has mandated that federal employee health insurance plans cease coverage for gender-affirming care for transgender individuals starting next year, threatening contract termination for non-compliance. This directive removes previously existing exceptions for those undergoing treatment, effectively ending all coverage for gender transition in these plans. These new restrictions impact over 11 million individuals, forcing them to pay out-of-pocket for necessary care or seek employment elsewhere, and represent a significant step in a wider effort to restrict transgender healthcare access.

Read More

Trump Worst President This Century on Key Issues Polling Shows

Recent polling data paints a stark picture of Donald Trump’s presidency, suggesting he stands out as the worst of this century on a crucial issue. While discussions often expand to encompass his entire tenure and character, this specific data point focuses on a particularly weak performance, igniting considerable debate about his impact.

The criticism suggests a consistent pattern of poor decision-making and a fundamental lack of competence, extending beyond just one area. Many feel he has actively worked against the nation’s well-being, dismantling positive aspects and exacerbating existing problems. This perspective implies that his presidency was not merely a case of underperformance, but rather a deliberate choice of “worse decisions” when faced with alternatives.… Continue reading

Vance Suspends $1.3 Billion Medicaid Payments to California

As part of the administration’s crackdown on Medicaid fraud, Vice President JD Vance announced the withholding of $1.3 billion in Medicaid payments to California, citing the state’s perceived lack of seriousness in prosecuting fraud. This action follows a similar suspension of payments to Minnesota earlier in the year and serves as a warning to all states that federal funding to their Medicaid Fraud Control Units could be suspended if they do not aggressively pursue fraud. The administration is also scrutinizing specific expenditures in California, including $630 million in billing, $500 million in home health services, and $200 million in questionable expenditures related to undocumented immigrants, who are not eligible for Medicaid. In addition to these actions, the Centers for Medicare and Medicaid Services (CMS) has imposed a six-month moratorium on new Medicare enrollment for hospices and home health agencies to intensify investigations and remove suspected fraudulent providers.

Read More

Senate Republicans Block Sanders Amendment to Cut Drug Prices

Senate Republicans voted to reject an amendment proposed by Sen. Bernie Sanders that sought to halve prescription drug prices in the United States by tying them to rates in Canada and other wealthy nations. While this amendment garnered support from all present Democrats and two Republicans, its failure underscores a partisan divide on drug pricing policy. This action contrasts with a previous executive order from President Trump aimed at aligning US prices with international benchmarks, though its effectiveness was limited without congressional action. Sanders’ amendment proposed a “most-favored-nation” pricing model, reflecting a broader legislative effort to curb what are demonstrably higher prescription drug costs for Americans compared to other developed countries.

Read More

Republicans Block Healthcare Cost Reduction Effort

It’s disheartening to see opportunities to make healthcare more affordable for everyday Americans repeatedly shut down, especially when it seems so clear that this is an issue weighing heavily on people’s minds. The recent actions that have essentially struck down chances to lower healthcare costs paint a rather grim picture of priorities. It’s baffling, frankly, to witness proposals aimed at easing the financial burden of medical care being rejected.

The sentiment is that such decisions aren’t just political disagreements; they feel like a deliberate choice to prioritize other interests over the well-being of the average citizen. When funds are readily available for global military engagements or for lavish spending that benefits a select few, the inability or unwillingness to allocate resources towards making healthcare accessible and affordable for everyone back home raises serious questions.… Continue reading

RFK Jr Defends Trump Math as “His Own Way” Ignoring Expert Criticism

During a Senate Finance Committee hearing, Health and Human Services Secretary Robert F. Kennedy Jr. defended President Trump’s claims of prescription drug price reductions by stating the president uses a unique calculation method. When pressed by Senator Elizabeth Warren on the mathematically impossible claims of 600% price cuts, Kennedy asserted that a reduction from $600 to $10 represents a 600% decrease. This statement drew criticism from mathematicians and highlighted how the TrumpRx website misleadingly promotes brand-name drugs at inflated prices, often with cheaper generic alternatives available, while pharmaceutical companies receive tariff exemptions. Further scrutiny revealed that most drugs on TrumpRx do not offer lower prices, and reports indicate upcoming price hikes on numerous medications.

Read More